-02 07:59:05
}
06-02 07:59:11
[MONITOR] Memory usage: RSS=253MB, Heap=108MB
06-02 07:59:11
[MONITOR] Active jobs: 2
06-02 07:59:35
[2025-06-02T04:59:35.181Z] generateObject attempt 3 failed {
06-02 07:59:35
"name": "AI_NoObjectGeneratedError",
06-02 07:59:35
"cause": {
06-02 07:59:35
"name": "AI_JSONParseError",
06-02 07:59:35
"cause": {},
06-02 07:59:35
"text": "\n{\n\"reportMarkdown\": \"# Technical Analysis and Recent Developments of WHOOP 4.0: A 2024-2025 Deep Dive\\n\\n## 1. Sensor Architecture & Biometric Accuracy\\n\\n### 1.1 Multi-LED Photoplethysmography System\\nWHOOP 4.0's sensor array combines **5 LEDs (red/infrared spectrum)** with **4 photodiodes**, enabling:\\n- **99.7% heart rate accuracy** vs ECG in controlled studies (Khodr et al. 2024 systematic review)\\n- **99% HRV precision** for rMSSD measurements (3rd-party validation)\\n- **10% improved heart rate tracking** over WHOOP 3.0 through Sila Nanotechnologies battery optimization\\n\\n### 1.2 Motion Artifact Mitigation\\n2024 WHOOP Labs testing with 4,000 participants (50M heartbeats analyzed) demonstrated:\\n- **<3.8 BPM error** during steady-state activities\\n- **58% of readings within 5 BPM** of chest strap during HIIT\\n- **92±6% wake detection specificity** unaffected by evening exercise (2024 clinical validation)\\n\\n## 2. Sleep Staging Capabilities & Limitations\\n\\n### 2.1 Four-Stage Classification Performance\\n2024 validation against polysomnography (Parent et al.) revealed:\\n| Sleep Stage | Agreement Rate | Cohen's κ |\\n|-------------|----------------|-----------|\\n| N1/N2 | 64±8% | 0.36 |\\n| N3 (SWS) | 80±7% | 0.39 |\\n| REM | 83±7% | 0.38 |\\n\\n### 2.2 Technical Constraints\\n- **54% dependency on respiratory rate** vs EEG for light sleep identification (Aziz et al. 2025)\\n- **7.3% underdetection** of slow-wave sleep phases impacting recovery metrics\\n- **15ms variance** in HRV measurements during SWS compared to wake states\\n\\n## 3. Post-2023 Ecosystem Developments\\n\\n### 3.1 Recovery Analytics Advancements\\n- **CLEAR Partnership Findings (2024):**\\n - 5-day sleep restoration post-travel (52 vs 62min deficit)\\n - 7-day stress normalization via HRV/RHR metrics\\n - Dataset: 11,914 members, 907,249 days/nights analyzed\\n\\n### 3.2 Clinical Integration Challenges\\n- **Datavant Partnership Status:**\\n - No peer-reviewed outcomes through 2024\\n - Mismatch in therapeutic focus (23 oncology/rare disease trials vs WHOOP's wellness data)\\n - Potential embargoed data from NCT04658914 (respiratory rate study since 2020)\\n\\n### 3.3 Regulatory Landscape Shifts\\n- **NIH Complement-ARIE Program:** $400M funding for AI/ML validation frameworks\\n- **EU ASPIS Cluster:** €60M for human-centric sensor validation\\n- **FAIR Data Gaps:** Only 9/28 biomedical databases meet ≥70% interoperability standards\\n\\n## 4. Competitive Benchmarking (2024-2025)\\n\\n### 4.1 Accuracy Matrix\\n| Metric | WHOOP 4.0 | Oura Gen3 | Fitbit Charge6 | Garmin Vivosmart5 |\\n|-----------------|-----------|-----------|----------------|--------------------|\\n| HR vs ECG | 99.7% | 93% | 89-92% | 95% |\\n| HRV (rMSSD) | 99% | 93% | N/A | 88% |\\n| Sleep Stage κ | 0.36-0.39 | 0.41-0.43 | 0.28-0.31 | 0.33-0.35 |\\n| Clinical Feas* | 4/9 | 5/9 | 3/9 | 4/9 |\\n\\n*Per Mayo Clinic validation (COSMIN/ISO 2025 criteria)\\n\\n### 4.2 Cost-Performance Analysis\\n-"
06-02 07:59:35
},
06-02 07:59:35
"text": "\n{\n\"reportMarkdown\": \"# Technical Analysis and Recent Developments of WHOOP 4.0: A 2024-2025 Deep Dive\\n\\n## 1. Sensor Architecture & Biometric Accuracy\\n\\n### 1.1 Multi-LED Photoplethysmography System\\nWHOOP 4.0's sensor array combines **5 LEDs (red/infrared spectrum)** with **4 photodiodes**, enabling:\\n- **99.7% heart rate accuracy** vs ECG in controlled studies (Khodr et al. 2024 systematic review)\\n- **99% HRV precision** for rMSSD measurements (3rd-party validation)\\n- **10% improved heart rate tracking** over WHOOP 3.0 through Sila Nanotechnologies battery optimization\\n\\n### 1.2 Motion Artifact Mitigation\\n2024 WHOOP Labs testing with 4,000 participants (50M heartbeats analyzed) demonstrated:\\n- **<3.8 BPM error** during steady-state activities\\n- **58% of readings within 5 BPM** of chest strap during HIIT\\n- **92±6% wake detection specificity** unaffected by evening exercise (2024 clinical validation)\\n\\n## 2. Sleep Staging Capabilities & Limitations\\n\\n### 2.1 Four-Stage Classification Performance\\n2024 validation against polysomnography (Parent et al.) revealed:\\n| Sleep Stage | Agreement Rate | Cohen's κ |\\n|-------------|----------------|-----------|\\n| N1/N2 | 64±8% | 0.36 |\\n| N3 (SWS) | 80±7% | 0.39 |\\n| REM | 83±7% | 0.38 |\\n\\n### 2.2 Technical Constraints\\n- **54% dependency on respiratory rate** vs EEG for light sleep identification (Aziz et al. 2025)\\n- **7.3% underdetection** of slow-wave sleep phases impacting recovery metrics\\n- **15ms variance** in HRV measurements during SWS compared to wake states\\n\\n## 3. Post-2023 Ecosystem Developments\\n\\n### 3.1 Recovery Analytics Advancements\\n- **CLEAR Partnership Findings (2024):**\\n - 5-day sleep restoration post-travel (52 vs 62min deficit)\\n - 7-day stress normalization via HRV/RHR metrics\\n - Dataset: 11,914 members, 907,249 days/nights analyzed\\n\\n### 3.2 Clinical Integration Challenges\\n- **Datavant Partnership Status:**\\n - No peer-reviewed outcomes through 2024\\n - Mismatch in therapeutic focus (23 oncology/rare disease trials vs WHOOP's wellness data)\\n - Potential embargoed data from NCT04658914 (respiratory rate study since 2020)\\n\\n### 3.3 Regulatory Landscape Shifts\\n- **NIH Complement-ARIE Program:** $400M funding for AI/ML validation frameworks\\n- **EU ASPIS Cluster:** €60M for human-centric sensor validation\\n- **FAIR Data Gaps:** Only 9/28 biomedical databases meet ≥70% interoperability standards\\n\\n## 4. Competitive Benchmarking (2024-2025)\\n\\n### 4.1 Accuracy Matrix\\n| Metric | WHOOP 4.0 | Oura Gen3 | Fitbit Charge6 | Garmin Vivosmart5 |\\n|-----------------|-----------|-----------|----------------|--------------------|\\n| HR vs ECG | 99.7% | 93% | 89-92% | 95% |\\n| HRV (rMSSD) | 99% | 93% | N/A | 88% |\\n| Sleep Stage κ | 0.36-0.39 | 0.41-0.43 | 0.28-0.31 | 0.33-0.35 |\\n| Clinical Feas* | 4/9 | 5/9 | 3/9 | 4/9 |\\n\\n*Per Mayo Clinic validation (COSMIN/ISO 2025 criteria)\\n\\n### 4.2 Cost-Performance Analysis\\n-",
06-02 07:59:35
"response": {
06-02 07:59:35
"id": "ad64e922-b835-4b61-9ef6-bb59d58ecfbf",
06-02 07:59:35
"timestamp": "2025-06-02T04:59:06.000Z",
06-02 07:59:35
"modelId": "accounts/fireworks/models/deepseek-r1"
06-02 07:59:35
},
06-02 07:59:35
"usage": {
06-02 07:59:35
"promptTokens": 2138,
06-02 07:59:35
"completionTokens": 2048,
06-02 07:59:35
"totalTokens": 4186
06-02 07:59:35
}
06-02 07:59:35
}
06-02 07:59:37
at async (/home/runner/workspace/node_modules/ai/core/telemetry/record-span.ts:18:22)
06-02 07:59:37
at async generateObjectWithRetry (/home/runner/workspace/src/utils.ts:17:14)
06-02 07:59:37
at async writeFinalReport (/home/runner/workspace/src/deep-research.ts:132:15)
06-02 07:59:37
at async (/home/runner/workspace/src/api.ts:193:22) {
06-02 07:59:37
cause: [SyntaxError: Unterminated string in JSON at position 3154 (line 3 column 3152)],
